Bendamustine in Patients with Rituximab-Refractory Indolent and Transformed non-Hodgkin's Lymphoma: Results from a Phase II Multicenter, Single-Agent Study
Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, LaCasce AS, Fayad LE, Bessudo A, Camacho ES, Williams ME, van der Jagt RH, Oliver JW, Cheson BD. Bendamustine in Patients with Rituximab-Refractory Indolent and Transformed non-Hodgkin's Lymphoma: Results from a Phase II Multicenter, Single-Agent Study. J Clin Oncol. 2008; 26(2):204-210.